ArticleCancer medicine2023

The relationship between clinicopathological variables, systemic inflammation, and CT-derived body composition with survival in patients with advanced non-small cell lung cancer receiving nivolumab as a second-line treatment.

Randa Saeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.